Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

Clinical trial NCT00651729 · COMPLETED

Trial details

NCT number: NCT00651729
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Muscle Spasticity

Start date: 2003-04-01
Primary completion: 2004-12-01
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.